BioSpace News Archive

Trevi Therapeutics, Inc. today announced that on March 7, 2023, the United States Patent and Trademark Office (“USPTO”) issued a notice of allowance for nalbuphine ER’s method of treatment of chronic cough in IPF.

Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 33rd Annual Oppenheimer Healthcare Conference taking place March 13-15, 2023.

Fujirebio Holdings Inc., its wholly-owned subsidiary Fujirebio Diagnostics, Inc., and AriBio Co., Ltd. announced a strategic partnership to advance the development of biomarkers for Alzheimer’s disease and other neurodegenerative conditions.

Cybin Inc. is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a virtual fireside chat at the Oppenheimer 33rd Annual Healthcare Conference taking place on March 13-15, 2023.

Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces publication of key data in the peer-reviewed journal Molecules.

Combined Therapeutics Inc. today announced the appointment of three highly accomplished biopharma executives to its board of directors.

Anebulo Pharmaceuticals, Inc. today announced the appointment of Sandra Gardiner as the Company’s acting chief financial officer.

Astria Therapeutics, Inc. will report fourth quarter/full year 2022 financial results before the Nasdaq Global Market open on Wednesday, March 22, 2023.

Lantern Pharma Inc. today announced that it will host a virtual key opinion leader (KOL) webinar on March 21, 2023 at 12:00 p.m. ET focusing on synthetic lethality, the unique and powerful mechanism of action behind Lantern’s drug candidates LP-184, LP-284, and LP-100.

SonALAsense today announced that the first cohort in SDT-202 was fully enrolled. SDT-202 is an open-label, dose-escalation trial of SDT in recurrent glioblastoma (rGBM).